<?xml version='1.0' encoding='UTF-8'?>
<xml>
<title>Illinois General Assembly - Bill Status for HB 3454</title>
<shortdesc>EPINEPHRINE DELIVERY DEVICE</shortdesc>
<sponsor>
<sponsorhead1>House Sponsors</sponsorhead1><sponsors>Rep. Joyce Mason-Martha Deuter-Janet Yang Rohr, Jawaharial Williams, Harry Benton, Dagmara Avelar, Camille Y. Lilly and Michelle Mussman</sponsors>
<sponsorhead2>Senate Sponsors</sponsorhead2><altsponsors>(Sen. Suzy Glowiak Hilton)</altsponsors>
</sponsor>
<lastaction>
<statusdate>3/26/2026</statusdate><chamber>Senate</chamber><action>Referred to Assignments</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>20 ILCS 2610/40</reference><aliasreference></aliasreference><reference>50 ILCS 705/10.19</reference><aliasreference></aliasreference><reference>105 ILCS 5/22-30</reference><aliasreference></aliasreference><reference>215 ILCS 5/356z.33</reference><aliasreference></aliasreference><reference>225 ILCS 60/65</reference><aliasreference></aliasreference><reference>410 ILCS 27/1</reference><aliasreference></aliasreference><reference>410 ILCS 27/5</reference><aliasreference></aliasreference><reference>410 ILCS 27/10</reference><aliasreference></aliasreference><reference>410 ILCS 27/15</reference><aliasreference></aliasreference><reference>410 ILCS 27/20</reference><aliasreference></aliasreference><reference>410 ILCS 607/10</reference><aliasreference></aliasreference><reference>410 ILCS 620/3.21</reference><aliasreference>from Ch. 56 1/2, par. 503.21</aliasreference><reference>410 ILCS 642/20</reference><aliasreference></aliasreference><SynopsisText>     Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.</SynopsisText></synopsis>
<actions>
<statusdate>2/7/2025</statusdate><chamber>House</chamber><action>Filed with the Clerk by Rep. Joyce Mason</action>
<statusdate>2/18/2025</statusdate><chamber>House</chamber><action>First Reading</action>
<statusdate>2/18/2025</statusdate><chamber>House</chamber><action>Referred to Rules Committee</action>
<statusdate>3/11/2025</statusdate><chamber>House</chamber><action>Assigned to Prescription Drug Affordability &amp; Accessibility Committee</action>
<statusdate>3/19/2025</statusdate><chamber>House</chamber><action>Do Pass / Short Debate Prescription Drug Affordability &amp; Accessibility Committee;  013-000-000</action>
<statusdate>3/20/2025</statusdate><chamber>House</chamber><action>Placed on Calendar 2nd Reading - Short Debate</action>
<statusdate>3/26/2025</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Jawaharial Williams</action>
<statusdate>3/26/2025</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Harry Benton</action>
<statusdate>3/26/2025</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Dagmara Avelar</action>
<statusdate>3/26/2025</statusdate><chamber>House</chamber><action>Second Reading - Short Debate</action>
<statusdate>3/26/2025</statusdate><chamber>House</chamber><action>Held on Calendar Order of Second Reading - Short Debate</action>
<statusdate>4/8/2025</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Camille Y. Lilly</action>
<statusdate>4/11/2025</statusdate><chamber>House</chamber><action>Rule 19(a) / Re-referred to Rules Committee</action>
<statusdate>1/21/2026</statusdate><chamber>House</chamber><action>Added Chief Co-Sponsor Rep. Martha Deuter</action>
<statusdate>2/11/2026</statusdate><chamber>House</chamber><action>Approved for Consideration Rules Committee;  005-000-000</action>
<statusdate>2/13/2026</statusdate><chamber>House</chamber><action>Placed on Calendar 2nd Reading - Short Debate</action>
<statusdate>2/25/2026</statusdate><chamber>House</chamber><action>Placed on Calendar Order of 3rd Reading - Short Debate</action>
<statusdate>2/25/2026</statusdate><chamber>House</chamber><action>Third Reading - Short Debate - Passed 105-000-000</action>
<statusdate>2/26/2026</statusdate><chamber>Senate</chamber><action>Arrive in Senate</action>
<statusdate>2/26/2026</statusdate><chamber>Senate</chamber><action>Placed on Calendar Order of First Reading March 3, 2026</action>
<statusdate>3/2/2026</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Michelle Mussman</action>
<statusdate>3/9/2026</statusdate><chamber>House</chamber><action>Added Chief Co-Sponsor Rep. Janet Yang Rohr</action>
<statusdate>3/26/2026</statusdate><chamber>Senate</chamber><action>Chief Senate Sponsor Sen. Suzy Glowiak Hilton</action>
<statusdate>3/26/2026</statusdate><chamber>Senate</chamber><action>First Reading</action>
<statusdate>3/26/2026</statusdate><chamber>Senate</chamber><action>Referred to Assignments</action>
</actions>
</xml>
